RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Trial details
- Registry ID
- NCT01490086
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086 | Reviva Pharmaceuticals | Phase 2 | Completed | 2013-03Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |